Faculty

Judd Walson

Adjunct Professor, Epidemiology
Professor, Global Health
Professor, Medicine - Allergy and Infectious Dis.
Professor, Pediatrics
Vice Chair, Global Health

206-685-8254
walson@uw.edu

Education

MPH Tufts University, 2000
BA Anthropology, Pitzer College, 1993
MD Tufts University, 2000

Contact

206-685-8254
walson@uw.edu

University of Washington
325 Ninth Avenue, Box 359909
Seattle, WA 98104

Bio

Dr. Walson is an infectious disease physician and the Vice Chair of the Department of Global Health and a Professor of Global Health, Medicine, Pediatrics and Epidemiology. He has extensive experience working in research, public health programming, policy development, product development and clinical practice. His research focuses on interventions to improve child survival, growth and development Africa and South-Asia. He collaborates with ministries of health, NGO’s and academic partners in Bangladesh, Benin, Burkina Faso, India, Kenya, Malawi, Nepal, Pakistan, Thailand and Uganda. He also serves as the principal investigator of several large multi-country clinical trials where he has successfully developed and strengthened international partnerships across academic, public health, industry, governmental and multilateral organizations.

Research Areas

Research Interests

Dr. Walson is a Professor at the University of Washington. He completed his training in both Internal Medicine and Pediatrics at Duke University, a fellowship in Infectious Disease at the University of Washington, and holds a Masters in Public Health from Tufts University. Dr. Walson has extensive experience in the design and implementation of large clinical trials in resource-limited settings. He has worked extensively in Kenya, Ethiopia, Bangladesh, Thailand and Nepal. Dr. Walson is particularly interested in the effect of enteric infection and composition on immunologic function and growth. Dr. Walson is the Principal Investigator for DeWorm3, which aims to demonstrate the feasibility of interrupting the transmission of soil transmitted helminths. Dr. Walson is also the Co-Director of CHAIN, a large clinical platform in five countries in Africa and Asia designed to evaluate mortality and morbidity among acutely ill children with varying degrees of malnutrition and to develop and test interventions for this high risk population. In addition to his clinical research, Dr. Walson is the Director of the Global Health Strategic Analysis and Research Training Program (START), an innovative collaboration between the Bill & Melinda Gates Foundation and the University of Washington.

Recent Publications (PubMed)

Defining optimal implementation packages for delivering community-wide mass drug administration for soil-transmitted helminths with high coverage.
(2022 Jun 18)
BMC Health Serv Res 22(1): 792
Gwayi-Chore MC, Aruldas K, Avokpaho E, Chirambo CM, Kaliappan SP, Houngbégnon P, Togbevi CI, Chabi F, Nindi P, Simwanza J, Johnson J, Miech EJ, Kalua K, Ibikounlé M, Ajjampur SSR, Weiner BJ, Walson JL, Means AR
It depends on how you tell: a qualitative diagnostic analysis of the implementation climate for community-wide mass drug administration for soil-transmitted helminth.
(2022 Jun 14)
BMJ Open 12(6): e061682
Avokpaho E, Lawrence S, Roll A, Titus A, Jacob Y, Puthupalayam Kaliappan S, Gwayi-Chore MC, Chabi F, Togbevi CI, Elijan AB, Nindi P, Walson JL, Ajjampur SSR, Ibikounle M, Kalua K, Aruldas K, Means AR
Family-Assisted Severity of Illness Monitoring for Hospitalized Children in Low-Resource Settings-A Two-Arm Interventional Feasibility Study.
(2022)
Front Pediatr 10(): 804346
von Saint Andre-von Arnim AO, Kumar RK, Clark JD, Wilfond BS, Nguyen QP, Mutonga DM, Zimmerman JJ, Oron AP, Walson JL
Antimicrobial resistance including Extended Spectrum Beta Lactamases (ESBL) among E. coli isolated from kenyan children at hospital discharge.
(2022 Mar)
PLoS Negl Trop Dis 16(3): e0010283
Tornberg-Belanger SN, Rwigi D, Mugo M, Kitheka L, Onamu N, Ounga D, Diakhate MM, Atlas HE, Wald A, McClelland RS, Soge OO, Tickell KD, Kariuki S, Singa BO, Walson JL, Pavlinac PB
Cytomegalovirus viremia predicts post-discharge mortality in Kenyan HIV-exposed uninfected children.
(2022 Feb 13)
J Infect Dis
Pavlinac P, Singa B, Huang ML, Shrestha L, Li V, Atlas HE, Diakhate MM, Brander R, Meshak L, Bogonko G, Tickell KD, McGrath CJ, Machuara IM, Ounga DO, Berkley J, Richardson BA, John-Stewart G, Walson JL, Slyker J
Show complete publication list